These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 29488114

  • 1. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.
    Mohammad IS, He W, Yin L.
    Pharm Res; 2018 Feb 27; 35(4):77. PubMed ID: 29488114
    [Abstract] [Full Text] [Related]

  • 2. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
    Mohammad IS, Teng C, Chaurasiya B, Yin L, Wu C, He W.
    Int J Pharm; 2019 Feb 25; 557():304-313. PubMed ID: 30599232
    [Abstract] [Full Text] [Related]

  • 3. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q, Song Y, Cheng X, Xu Z, Matthew OA, Wang J, Sun Z, Zhang X.
    Anticancer Res; 2019 Oct 25; 39(10):5461-5471. PubMed ID: 31570440
    [Abstract] [Full Text] [Related]

  • 4. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P, Chen X, Guo R, Chen X, Chen Z, Wei C, Li Y, Wang W, Zhou Y, Qin L.
    Mol Pharm; 2020 Apr 06; 17(4):1114-1126. PubMed ID: 32176509
    [Abstract] [Full Text] [Related]

  • 5. Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells.
    Xu W, Bae EJ, Lee MK.
    Int J Nanomedicine; 2018 Apr 06; 13():7549-7563. PubMed ID: 30532538
    [Abstract] [Full Text] [Related]

  • 6. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, Zhang Z.
    Mol Pharm; 2014 Sep 02; 11(9):3196-209. PubMed ID: 25102234
    [Abstract] [Full Text] [Related]

  • 7. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 8. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.
    Li H, Liu B, Ao H, Fu J, Wang Y, Feng Y, Guo Y, Wang X.
    J Nanobiotechnology; 2020 Jan 06; 18(1):4. PubMed ID: 31907045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
    Wang YZ, Fang XL, Li YJ, Zhang ZW, Han LM, Sha XY.
    Yao Xue Xue Bao; 2008 Jun 06; 43(6):640-6. PubMed ID: 18822969
    [Abstract] [Full Text] [Related]

  • 11. [Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].
    Huang R, Yao X, Chen Y, Sun X, Lin Y.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb 06; 33(1):108-14. PubMed ID: 27382749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells.
    Hyuga S, Shiraishi M, Hori A, Hyuga M, Hanawa T.
    Biol Pharm Bull; 2012 Feb 06; 35(10):1729-39. PubMed ID: 23037162
    [Abstract] [Full Text] [Related]

  • 14. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures.
    Xie X, Shao X, Ma W, Zhao D, Shi S, Li Q, Lin Y.
    Nanoscale; 2018 Mar 28; 10(12):5457-5465. PubMed ID: 29484330
    [Abstract] [Full Text] [Related]

  • 15. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C, Guan W, Peng J, Chen Y, Xu G, Dou H.
    Acta Biomater; 2020 Feb 28; 103():247-258. PubMed ID: 31846802
    [Abstract] [Full Text] [Related]

  • 16. A personalized and long-acting local therapeutic platform combining photothermal therapy and chemotherapy for the treatment of multidrug-resistant colon tumor.
    Wang B, Wu S, Lin Z, Jiang Y, Chen Y, Chen ZS, Yang X, Gao W.
    Int J Nanomedicine; 2018 Feb 28; 13():8411-8427. PubMed ID: 30587968
    [Abstract] [Full Text] [Related]

  • 17. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J, Zhao X, Chen Q, Yin X, Xin X, Li K, Qiao M, Hu H, Chen D, Zhao X.
    Acta Biomater; 2017 Mar 01; 50():381-395. PubMed ID: 27956367
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y, Zhou C, Wei S, Yang T, Lan Y, Cao A, Yang J, Hou Y.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():330-340. PubMed ID: 29936386
    [Abstract] [Full Text] [Related]

  • 19. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X, Gao Y, Chen L, Zhang Z, Deng Y, Li Y.
    Int J Pharm; 2012 Jan 17; 422(1-2):390-7. PubMed ID: 22001531
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C, Zhao X, Yang Y, Liu S, Liu Y, Li X.
    Med Sci Monit; 2018 May 03; 24():2750-2757. PubMed ID: 29723165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.